Keywords: EULAR, Roche, RoActemra, Abbott Labs, Humira, Rheumatoid arthritis, Spondyloarthritis

Roche's RoActemra beats leading rival Humira in RA study; other news from EULAR

Article | 07 June 2012

Print This

Swiss drug major Roche (ROG: SIX) yesterday released new data from the ADACTA study which showed that adult rheumatoid arthritis ( ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in